BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21308316)

  • 1. Febrile ulceronecrotic Mucha-Habermann disease in adult patient successfully treated with systemic corticosteroid.
    Nassif PW; Godoy DA; Nakandakari S; Alves CJ; Soares CT
    An Bras Dermatol; 2010; 85(6):891-4. PubMed ID: 21308316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Febrile ulceronecrotic Mucha-Habermann disease].
    Arellano Lorca J; Yáñez Silva I; Soto Vilches F; Luna Heine A; Corredoira Salum Y
    Rev Med Chil; 2016 Sep; 144(9):1214-1217. PubMed ID: 28060985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of febrile ulceronecrotic Mucha-Habermann disease responsive to systemic corticosteroids.
    Rai E; Kamzan A; Boozalis E; Hogeling M; Fong K
    Pediatr Dermatol; 2023; 40(3):573-575. PubMed ID: 36573550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature.
    Sotiriou E; Patsatsi A; Tsorova C; Lazaridou E; Sotiriadis D
    Acta Derm Venereol; 2008; 88(4):350-5. PubMed ID: 18709304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Febrile Ulceronecrotic Mucha-Habermann Disease: A Case Report and Review of Literature in the Paediatric Population.
    Liu J; Zhong J; Wang Q; Cai Y; Chen J
    Acta Derm Venereol; 2023 Apr; 103():adv4806. PubMed ID: 37073962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Febrile ulceronecrotic Mucha-Habermann disease with central nervous system vasculitis.
    Rosman IS; Liang LC; Patil S; Bayliss SJ; White AJ
    Pediatr Dermatol; 2013; 30(1):90-3. PubMed ID: 22276640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febrile ulceronecrotic Mucha-Habermann disease during pregnancy: A case report.
    Avcı C; Gürbüz Ö; Özbağçıvan Ö; Lebe B
    Australas J Dermatol; 2023 May; 64(2):245-248. PubMed ID: 37002720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Febrile ulceronecrotic Mucha-Habermann disease: treatment with infliximab and intravenous immunoglobulins and review of the literature.
    Meziane L; Caudron A; Dhaille F; Jourdan M; Dadban A; Lok C; Chaby G
    Dermatology; 2012; 225(4):344-8. PubMed ID: 23391565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Febrile Ulceronecrotic Mucha-Habermann Disease: Two Cases with Excellent Response to Methotrexate.
    Griffith-Bauer K; Leitenberger SL; Krol A
    Pediatr Dermatol; 2015; 32(6):e307-8. PubMed ID: 26584702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Febrile ulceronecrotic Mucha-Habermann disease (pityriasis lichenoides et varioliformis acuta fulminans) presenting as Stevens-Johnson syndrome.
    Kaufman WS; McNamara EK; Curtis AR; Kosari P; Jorizzo JL; Krowchuk DP
    Pediatr Dermatol; 2012; 29(2):135-40. PubMed ID: 22084981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature.
    Suárez J; López B; Villalba R; Perera A
    Dermatology; 1996; 192(3):277-9. PubMed ID: 8726649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Febrile ulceronecrotic Mucha-Habermann disease in a 34-month-old boy: a case report and review of the literature.
    Perrin BS; Yan AC; Treat JR
    Pediatr Dermatol; 2012; 29(1):53-8. PubMed ID: 21906156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid recovery in a child with febrile ulceronecrotic Mucha-Habermann disease following intravenous immunoglobulin administration.
    Somasundaram A; Gupta A; Sathishkumar D; Mathew L; George A; Thomas M
    Pediatr Dermatol; 2024; 41(3):518-522. PubMed ID: 38234081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity?
    Cozzio A; Hafner J; Kempf W; Häffner A; Palmedo G; Michaelis S; Gilliet M; Zimmermann D; Burg G
    J Am Acad Dermatol; 2004 Dec; 51(6):1014-7. PubMed ID: 15583604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Febrile ulceronecrotic Mucha-Habermann disease.
    López-Estebaranz JL; Vanaclocha F; Gil R; García B; Iglesias L
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 2):903-6. PubMed ID: 8408838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Febrile ulceronecrotic Mucha-Habermann disease].
    Dupin A; Bosset D; Atger L; Chevallier B; Saiag P; Benoist G
    Arch Pediatr; 2016 Jan; 23(1):82-5. PubMed ID: 26552626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Diagnostically Challenging Case of Febrile Ulceronecrotic Mucha-Habermann Disease in an Adult Female Successfully Treated with Methotrexate and Cyclosporine.
    Ngo T; Hossain C; Cohen J; McLellan B; Blasiak R; Balagula E
    Case Rep Dermatol; 2021; 13(1):12-17. PubMed ID: 33613228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Febrile ulceronecrotic Mucha-Habermann disease in an 8-year-old boy responding to methotrexate.
    Alratrout J; Alshammasi F; Ansari N
    Int J Dermatol; 2016 Nov; 55(11):1205-1209. PubMed ID: 27368714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Febrile ulceronecrotic Mucha-Habermann disease: a case with systemic symptoms managed with subcutaneous methotrexate.
    Lin CY; Cook J; Purvis D
    Australas J Dermatol; 2012 Nov; 53(4):e83-6. PubMed ID: 23157793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febrile ulceronecrotic Mucha-Habermann disease: proposed diagnostic criteria and therapeutic evaluation.
    Nofal A; Assaf M; Alakad R; Amer H; Nofal E; Yosef A
    Int J Dermatol; 2016 Jul; 55(7):729-38. PubMed ID: 26695875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.